As shown in the human protein atlas database, the high expression of SLC7A11 resulted in poor prognosis (P<0.01, Figure 3A), but GPX4 did not affect the prognosis of RCC (P=0.14, Figure 3B). Here, GPX4 is linked to renal cell carcinoma.